Evidence map›Paper›PMID 42482509›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Chemically Evolved XNAzyme Platforms for Effective In Vivo Gene Regulation.

Jun Wang, Jiansong Zhou, Yimin Zhou, Weigang Wang, Yilin Zhao, Yuhan Yi, Yan Li, Yuanxiang Zhu, Qinmiao Sun, Dahua Chen

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jun WangInstitute of Biomedical Research, Yunnan University, Kunming, China.ORCID 0000-0002-7298-9861
Jiansong ZhouInstitute of Biomedical Research, Yunnan University, Kunming, China.
Yimin ZhouInstitute of Biomedical Research, Yunnan University, Kunming, China.
Weigang WangInstitute of Biomedical Research, Yunnan University, Kunming, China.
Yilin ZhaoInstitute of Biomedical Research, Yunnan University, Kunming, China.ORCID 0000-0003-1250-2764
Yuhan YiInstitute of Biomedical Research, Yunnan University, Kunming, China.
Yan LiInstitute of Biomedical Research, Yunnan University, Kunming, China.
Yuanxiang ZhuInstitute of Biomedical Research, Yunnan University, Kunming, China.
Qinmiao SunState Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Dahua ChenInstitute of Biomedical Research, Yunnan University, Kunming, China.ORCID 0000-0002-2122-9141

Funding

Excellence Research Group Program 32588201National Key R&D Program of China 2021YFA0805800National Key R&D Program of China 2023YFA1801900Yunnan Provincial Science and Technology Department 202105AB160002
6 · The paper itself

Abstract

DNAzymes are programmable nucleic acid catalysts for RNA cleavage, but their application in biological systems is limited by low catalytic efficiency and poor stability under physiological conditions. Here we report the chemical evolution of the 8-17 DNAzyme to generate xeno-nucleic acid enzymes (XNAzymes) with enhanced functionality. Through rational modifications of sugar and backbone components within the catalytic core, the optimized XNAzyme exhibits up to a 14-fold increase in catalytic activity under near-physiological conditions while fully preserving sequence programmability and structural modularity. Additional terminal modifications improve nuclease resistance and reduce RNase H-mediated degradation, favoring efficient catalytic RNA cleavage. Functionally, the XNAzyme platform enables sequence-specific silencing of both exogenous and endogenous mRNAs in mammalian cells, and can be programmed to cleave oncogenic miRNA, resulting in upregulation of downstream genes. In zebrafish embryos, XNAzyme-mediated RNA targeting induces gene-specific developmental alterations. This study establishes chemical evolution of the catalytic core as a general strategy to enhance the performance of nucleic acid enzymes and highlights XNAzyme as a versatile platform for programmable RNA regulation in complex biological environments.

Indexed as

DNA, CatalyticGene Expression RegulationAnimalsHumansMicroRNAsZebrafishDNA, CatalyticMicroRNAschemical evolutionDNAzymesgene regulationgene silencingxeno‐nucleic acids

Identifiers

PMID42482509
PMCPMC13549052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.